Cargando…
Transfer of mesenchymal stem cell mitochondria to CD4(+) T cells contributes to repress Th1 differentiation by downregulating T-bet expression
BACKGROUND: Mesenchymal stem/stromal cells (MSCs) are multipotent cells with strong tissue repair and immunomodulatory properties. Due to their ability to repress pathogenic immune responses, and in particular T cell responses, they show therapeutic potential for the treatment of autoimmune diseases...
Autores principales: | Akhter, Waseem, Nakhle, Jean, Vaillant, Loïc, Garcin, Geneviève, Le Saout, Cécile, Simon, Matthieu, Crozet, Carole, Djouad, Farida, Jorgensen, Christian, Vignais, Marie-Luce, Hernandez, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875419/ https://www.ncbi.nlm.nih.gov/pubmed/36694226 http://dx.doi.org/10.1186/s13287-022-03219-x |
Ejemplares similares
-
Mesenchymal stem cell repression of Th17 cells is triggered by mitochondrial transfer
por: Luz-Crawford, Patricia, et al.
Publicado: (2019) -
Multifaceted Roles of Mitochondrial Components and Metabolites in Metabolic Diseases and Cancer
por: Nakhle, Jean, et al.
Publicado: (2020) -
Transfer of Cardiac Mitochondria Improves the Therapeutic Efficacy of Mesenchymal Stem Cells in a Preclinical Model of Ischemic Heart Disease
por: Vignais, Marie-Luce, et al.
Publicado: (2023) -
Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway
por: Luz-Crawford, Patricia, et al.
Publicado: (2012) -
Mesenchymal Stem Cells Repress Th17 Molecular Program through the PD-1 Pathway
por: Luz-Crawford, Patricia, et al.
Publicado: (2012)